Skip to main content
Iranian Journal of Basic Medical Sciences logoLink to Iranian Journal of Basic Medical Sciences
. 2019 Oct;22(10):1147–1152. doi: 10.22038/ijbms.2019.34888.8281

Does biofilm formation have different pathways in Staphylococcus aureus?

Ali Shivaee 1, Behrooz Sadeghi Kalani 1, Malihe Talebi 1, Davood Darban-Sarokhalil 1,*
PMCID: PMC6885392  PMID: 31998455

Abstract

Objective(s):

Biofilm formation is one of the most important factors in the development of infections caused by Staphylococcus aureus. In this study, the expression levels of genes responsible for biofilm formation were studied in methicillin sensitive and methicillin resistant S. aureus.

Materials and Methods:

A total of 100 meticillin-resistant s.aureus (MRSA) and meticillin-sensetive s.aureus (MSSA) isolates were studied. Bacterial biofilm formation was evaluated phenotypically using microtiter plate method. Real-time PCR tests were conducted to determine the expression levels of genes involved in biofilm formation.

Results:

Quantitative biofilm formation test was repeated three times for each specimen. The prevalence of weak, medium, and strong biofilm producers were 16%, 49%, and 35%, respectively. In MSSA isolates, expression levels of ica genes increased compared to the fnbA, fnbB, clfA and clfB genes. These results were different in MRSA isolates, and ica genes showed a decreased gene expression levels compared to the aforementioned genes.

Conclusion:

Considering the results of this study, clf genes probably contribute to the same extent in both MRSA and MSSA isolates, and there is probably no significant difference in the role of these genes in these isolates. In addition, the results of this study indicated that MRSA may not use the conventional route for biofilm formation and may use independent pathways through Polysaccharide intercellular adhesion (PIA).

Key Words: Biofilm, MRSA, MSSA, PIA, Staphylococcus aureus

Introduction

Staphylococcus aureus is a Gram-positive facultative anaerobic cocci. This bacterium is the most important clinical species among Staphylococci group (1). S. aureus was primarily isolated by a Scottish surgeon, Alexander Ogston, from an infectious abscess specimen in 1880 (2). This microorganism is considered as one of the most successful pathogenic bacteria successively colonizing human and animal skin and mucus. This microorganism is also considered as a potential human pathogen capable of causing infection in different body sites including skin, soft tissue, respiratory routes, skeleton, and the joints. This microorganism is a leading cause of nosocomial and community-acquired infections causing a variety of lethal human infections including endocarditis, osteomyelitis, pneumonia, and urinary tract infection (3-8). S. aureus is currently categorized in two groups of methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Methicillin-sensitive species were commonly isolated prior to the emergence of MRSAs (8). Methicillin-resistant bacteria are also resistant to other antibiotics (9). In 2007, studies showed that more than 65% of nosocomial infections were caused by biofilm-forming microorganisms (10). S. aureus is also a common pathogen associated with biofilm-related infections and a contaminant of medical devices, causing infection in a large number of patients annually. S. aureus has a high prevalence on human skin and mucus compared with other biofilm-forming pathogens (11). In MRSA and MSSA isolates, biofilm formation is considered as a virulence factor leading to the resistance to antibiotics and the toleration of harsh environmental conditions. Infections caused by this microorganism include endocarditis, septicemia, osteomyelitis, catheter-related urinary tract infection, and ventilator-related pneumonia (12, 13).

Biofilm formation on surfaces such as biological materials is possibly a major factor in the spread of the infection. Biofilm formation facilitates the aggregation and adherence of microorganism to solid surfaces (14). Adherence to various surfaces is a fundamental step in biofilm formation and bacterial aggregation. This adherence is facilitated by bacterial surface proteins called ‘‘ The Microbial Surface Components Recognizing Adhesive Matrix Molecules’’ (MSCRAMMs) (15). In fact, bacteria are able to produce biofilms through the formation of polysaccharide matrix. Polysaccharide intercellular adhesion (PIA) encoded by ica operon is required for biofilm formation in S. aureus (16). PIA is in fact a polysaccharide encoded by icaADBC operon and is formed by partially deacetylated β (1→6) glycose aminyl glycan bonds. This polysaccharide can surround the cell, protecting it against human immune system and antibiotics (17). In 2001, Cucarella, et al. reported PIA-independent biofilm formation in S. aureus isolated from sheep breast abscess. In these isolates, biofilm formation was mediated by biofilm-associated proteins (Bap) (18). ica-independent biofilm formation was confirmed in human S. aureus isolates (UAMS-1) in vivo and in vitro (19). Studies suggest that acquiring resistance to methicillin can lead to the suppression of PIA and surface protein-dependent biofilm formation (20).

This study aimed to investigate the expression levels of genes associated with biofilm formation in MRSA and MSSA isolated from clinical specimens in different cities of Iran. Understanding the expression levels of these genes help us to understand genetic mechanisms used by MRSA and MSSA isolates and to compare genetic pathways used by these two isolates.

Materials and Methods

Isolation of S. aureus

In this study, a total of 100 MRSA and MSSA isolates (isolated from burn wounds) were investigated. Bacteria were previously identified in the Microbiology Lab of Iran University of Medical Sciences by biochemical and molecular tests.

Figure 3.

Statistical analysis of clf gene between MRSA and MSSA isolates

Figure 3

MRSA: meticillin-resistant s.aureus; MSSA: meticillin-sensetive s.aureus

In vitro biofilm formation assay

The ability of biofilm formation was investigated in MRSA and MSSA isolates according to the previous studies (21). Briefly, 250 μl of both MRSA and MSSA isolates diluted 1:1000 in tryptic soy broth (TSB), supplemented with 1% glucose were inoculated in 96-well polystyrene microtitre plates and were incubated for 94 hr at 37 ºC. After biofilm formation, non-adherent bacterial cells were removed and washed twice with 200 μl of sterile phosphate buffer saline (PBS; pH 7.0). Cell were then stained with 300 μl of crystal violet (2%) after being dried in an inverted position at room temperature under laminar air flow. Then, the stained cells were washed 3 times with distilled water in order to remove the extra stain and 300 μl of ethanol: acetic acid (95:5 v/v) solution was added to each well. Then, 100 μl of this solution was transferred to another 96- well plate and absorbance was measured at 570 nm using Elisa reader (Merck, USA). Culture medium was used as a control. Isolates were classified in three categories: strong (OD570≥0.5), medium (OD570≥0.2 to <0.5) and weak (OD570 0 to <0.2) biofilm producers (22). Each test was done in triplicates.

RNA isolation

In order to induce biofilm formation, isolates from two groups of MRSA and MSSA were inoculated in TSB culture medium containing glucose 1% in 96-well microplate. The plates were then incubated at 37 ºC for 18 hr.

In brief, cells were washed in 6-well polystyrene plates with ddH2O three times. Bacterial cells with adherence to each well were disrupted and scraped from the plate surface by sterile micropipette tips and re-suspended in cold sterile distilled water. After centrifugation, pellets were washed with deionized water to remove the planktonic cells. Cells were centrifuged again and the supernatant was discarded. The cells were initially resuspended in tris-EDTA buffer (pH 7.5) containing 15 mg/ml lysozyme (Sigma-Aldrich), and 0.1 mg/ml lysostaphin (Sigma Aldrich). Then, the pellet was subsequently processed using the High pure RNA isolation kit (Roche, Germany) according to the manufacturer’s protocol.

The quality and quantity of RNA was determined by agarose gel electrophoresis and by measuring the absorbance at 260 and 280 nm using a Nanodrop spectrophotometer ND-1000 (Thermo Fisher Scientific, Wilmington, DE, USA). The Purified RNA was immediately converted to cDNA to avoid RNA degradation using first script RT reagent kit (Takara, Japan (according to the manufacturer’s instructions.

Primers design for qPCR

The primers were used in this study are shown in Table1. Annealing temperatures were optimized for each primer pair by melting curve analysis and by post-PCR agarose gel electrophoresis. The identities of all PCR products were confirmed and the amplification efficiency for each primer set was determined by a RT-qPCR assay in order to evaluate the linearity of target amplification.

Table 1.

Primers used in this study for qPCR

Reference Annealing temperature Sequence Gene NO
(35) 59 F: GAGGTAAAGCCAACGCACTC
R: CCTGTAACCGCACCAAGTTT
icaA 1
(35) 56 F: ACCCAACGCTAAAATCATCG
R: GCGAAAATGCCCATAGTTTC
icaD 2
(36) 55 F: TGAAGGTGGTTATGTTGATG
R: CAGTGTATCCTCCAACATGA
fnbA 3
(36) 60 F: GTAGAGGAAAGTGGGAGTTCAG
R: TGTGTTGATTGTGATGGTTGC
fnbB 4
(36) 55 F: TACAAGTGCGCCTAGAATGA
R: TTTGACATAACCTGCTTGGT
clfA 5
(36) 59 F: GTGTAGATACAGCTTCAGGTCA
R: CACTTACTTTACCGCTACTTTC
clfB 6
(36) 53 F: AGGTCTTGGAGAAATGAATG
R: CAAATGTTTGGTCCGCTT
gyrB 7

Quantitative real-time PCR

In order to understand the difference on genetic pathways of biofilm formation, 2-step real-time PCR was performed on 6 genes involved in biofilm formation. gyrB gene was used as an internal control. The reaction was carried out in a Qiagen r (roto gene 6000) using the SYBR Green Master Mix (Takara, japan) according to the manufacturer’s protocol. In brief, for each reaction, 2 µl of sample, 0.8 µl of each primer (Forward and Reverse) with the concentration of 10 picomol, 10 µl of SYBR Premix, and 6 µl of distilled water were used. The reaction started with an initial denaturation at 95 ºC for 5 min and 40 amplification cycles of 95 ºC for 20 sec, TM annealing for 25 sec and 72 ºC for 20 sec (Table 2).

Table 2.

Conditions required for real-time PCR reaction

Cycle Cycle Point
Hold @ 95°c, 10 min 0 s
Cycling (40 repeats) Step 1 @ 95°c, hold 20 s
  Step 2 @ TM°c(3-6 table), hold 25 s
  Step 3 @ 72°c, hold 20 s, acquiring to Cycling A([Green][1][1])
Melt (72-99°c) , hold secs on the 1st step, hold 5 secs on next steps, Melt A([Green][1][1])

Data analysis

For each sample, curves were drawn for both the target and endogenous references. Data were then subjected to analysis using the Relative Expression Software Tool (REST) program (Qiagen) and Rotor gene 6000 application.

Statistical analysis

Since data on icaA, clfA, and clfB genes were normalized, Independent Samples T-test was performed to compare them among MRSA and MSSA groups. Also, since data on icaD, fnbA, and fnbB genes were not normalized, Mann-Whitney test was performed to compare these genes among MRSA and MSSA groups.

Results

Biofilm formation assay

Quantitative test for biofilm formation was repeated three times for each sample and finally, optical absorbance was read by ELISA reader at 570 nm. Weak, intermediate, and strong biofilm formation were observed in 16 (16%), 49 (49%), and 35 (35%) of the isolates (Table 3), respectively.

Table 3.

Results of adhesion formation by microtiter plate method

Isolates % Test
Highly (%) Moderate (%) Weak (%) None (%) Biofilm formation
19 (19%) 26 (26 %) 9 (9%) 0(0%) MRSA Standard microtiter plate method
16 (16%) 23 (23%) 7 (7%) 0(0%) MSSA
35% 49% 15% 0(0%) Total

Real-time PCR

Values of CT for icaA , icaD , fnbA, fnbB, clfA, and clfB genes were compared with calibrated sample and calculated by Rotor gene. Among 100 studied isolates, 50 MRSA isolates and 50 MSSA isolates, higher expression levels of ica were observed in MSSA isolates compared to fnbB, clfA and clfB. These results were different in MRSA isolates and ica genes showed lower expression levels compared to other genes. Then, fold change of the studied genes in MRSA and MSSA isolates was calculated. In MSSA isolates, fold changes for icaA , icaD , fnbA , fnbB , clfA , clfB genes were 6.4, 6.6, 1.4, 1.7, 0.9, and 1, respectively (Figure 1). Interpretation of the results of fold change showed a slight difference in expression level of clf in MRSA and MSSA isolates.

Figure 1.

Results of changes in expression level of the studied genes after biofilm induction compared to the control sample in MRSA and MSSA isolates

Figure 1

MRSA: meticillin-resistant s.aureus; MSSA: meticillin-sensetive s.aureus

Statistical analysis

Results showed the significant difference between the expression levels of icaA, icaD, fnbA, and fnbB in the two studied groups (p-value< 0.05). However, no significant difference was observed between the expression levels of clfA and clfB among two studied groups (p value >0.05) (Table 4). Among MSSA and MRSA groups, icaA and icaD have the highest expression levels with the mean values of 6.4292 and 6.6869, respectively. While, fnbA and fnbB have higher expression levels of 7.1648 and 6.8864 compared to MSSA group (Figures 2-4).

Table 4.

Statistical analysis of different genes among the isolates

variable number Group Mean Standard deviation Test Results
IcaA 50 MRSA 1.5544 .840513 T-test T=-7.541 df=52.63
P-value < 0.001
50 MSSA 6.2926 4.36763
icaD 50 MRSA 1.2353 1.16400 Mann-Whitney Z=-7.671
P-value < 0.001
50 MSSA 6.6845 4.44121
fnbA 50 MRSA 7.0214 3.65111 Mann-Whitney Z=-8.009
P-value < 0.001
50 MSSA 1.4571 1.10468
fnbB 50 MRSA 7.2008 4.13546 Mann-Whitney Z=-7.46
P-value < 0.001
50 MSSA 1.7308 .75027
clfA 50 MRSA .9600 .37710 T-test T= 0.900 df=98
P-value = 0.929
50 MSSA .9533 .36982
clfB 50 MRSA 1.2023 .76198 T-test T=1.089 df=98
P-value = 0.279
50 MSSA 1.0467 .66331

Figure 2.

Statistical analysis of ica and fnb genes among MRSA and MSSA isolates

Figure 2

MRSA: meticillin-resistant s.aureus; MSSA: meticillin-sensetive s.aureus

Figure 4.

Statistical comparison of the studied genes among MRSA and MSSA isolates

Figure 4

MRSA: meticillin-resistant s.aureus; MSSA: meticillin-sensetive s.aureus

Discussion

S. aureus is considered as the most important clinical species in Staphylococci genus (1). It is estimated that roughly 30% of all humans are asymptomatic carriers of this pathogen (2). This bacterium is also a common pathogen in biofilm-associated infections and medical device contaminations. This bacterium has a high prevalence compared to other biofilm-forming bacteria (11). Biofilm formation in MRSA and MSSA isolates is considered as a virulence factor and helps the bacteria to overcome harsh environmental conditions and to become resistant to antibiotics, causing various infections including endocarditis, septicemia, osteomyelitis, catheter-related urinary tract infection, and ventilator-related pneumonia. Moreover, there are different molecules such as collagen, fibronectin and fibrinogen in burn wounds, S. aureus by encoding many proteins that specifically interact with human cellular matrix components can colonize burn wounds (12, 13). The ability of biofilm formation on biological materials is considered as a major factor in the spread of the infection (14). In this study, 50 MRSA and 50 MSSA isolates from burn wounds were investigated and biofilm formation was observed among all the isolates. Weak, intermediate, and strong biofilm formation were observed among 16%, 49%, and 35% of isolates, respectively. These results were compatible with the results of the studies of Moghadam et al. in 2014. They concluded that among 65 isolates, 97% of MRSA isolates and 70% of MSSA isolates had the ability of biofilm formation (25). Also, in another study by Vasudevan et al. in 2010, among 35 studied isolates, 32 (91%) were capable of biofilm formation (26) which was similar to our study. Rohde et al. showed similar results in Staphylococci isolated from knee surgery. They reported that all isolates were capable of biofilm formation (27). However, results of our study showed higher biofilm formation compared to the studies conducted by Adilson Oliveira et al. in 2010 (46% of isolates showed strong adherence and 35% of isolates showed weak adherence), Kwon et al. in 2008, Knobloch et al. in 2004, and Fowler et al. in 2002 (28-31). These studies show that the prevalence of biofilm formation has increased in recent years which suggests the importance of the studies on biofilm formation pathways and novel therapeutic strategies. PIA secretory proteins and surface proteins encoded by ica operon are required in biofilm-producing bacteria. This operon provides the necessary proteins for PIA synthesis in Staphylococci species (16). One of the first reports on the presence of PIA-independent biofilm formation in S. aureus was given by Cucarella et al. in 2001. They were able to observe biofilm formation by biofilm-associated proteins (Bap) in sheep breast abscess isolates (18). Further studies suggest that acquiring resistance to methicillin can suppress surface protein and PIA-dependent biofilm formation (20). This challenge about PIA-independent biofilm formation shows that biofilm production and propagation has not yet been fully understood which suggest the need for studying different pathways for biofilm formation. The current study aimed to investigate the presence of different biofilm formation pathways in MRSA and MSSA isolates by real-time PCR and biofilm induction methods. This study was conducted on 50 MRSA and 50 SSA isolates. Our results showed the higher expression levels of ica gene in MSSA isolates compared to clfA, clfB, fnbA, and fnbB. These results were different in MRSA isolates and ica genes showed lowed expression levels compared to other genes. Fold change calculation for icaA, icaD, fnbA, fnbB, clfA, and clfB genes were 1.4, 1.5, 6.8, 7.1, 1.1, and 1.19, respectively. While, in MSSA isolates, these values were 6.4, 6.6, 1.4, 1.7, and 0.9, respectively. Fold change interpretations and statistical analyses clearly showed that there is a significant relationship between acquiring resistance to methicillin and pathways for biofilm formation. Results showed the increase in using PIA-independent pathway for biofilm formation in MRSA isolates. This was completely different for MSSA isolates which show PIA-dependent biofilm formation. Similar studies in 2010 were conducted by Boles et al. for the identification of the genes involved in PIA-independent biofilm formation in S. aureus. By inducing mutation in the expressed genes involved in PIA-independent biofilm formation in MRSA, they showed the intense decrease in biofilm formation levels in these isolates (32). In another study by O’neill et al. in 2007, biofilm formation in MRSA and MSSA isolates was investigated by the deletion of ica locus. They showed the capability of biofilm formation in MRSA isolates, but not in MSSA isolates (33). In 2008, they also showed that biofilm formation in MRSA isolates is affected and reduced by the deletion of fnbA and fnbB genes; while, this mutation in biofilm formation did not affect MSSA isolates (34). In the study of Shanks et al. it was suggested that MRSA isolates use PIA-independent pathways for biofilm formation (35). Also, in another similar study by Dastgheib et al. in 2014, it was suggested that MRSA isolates use fnb and clf genes for PIA-independent biofilm formation in joint fluids (36). However, our study did not show a significant difference among MSSA and MRSA isolates. Fold change comparison and statistical analysis shows that there is no significant difference in using clf gene in MRSA and MSSA isolates and it is probably used at the same levels in both MRSA and MSSA isolates. Unfortunately, no specific study has been conducted for these gene; therefore, more studies are required to better understand the role of this gene in biofilm formation pathway. In fact, the results of the current study showed that S. aureus isolates have possibly changed their common PIA-dependent pathway for biofilm formation and are using other pathways (including surface protein-dependent pathways).

Conclusion

According to the results of this study, clf gene possibly has an equivalent role in both groups and there is no significant difference for the role of this gene in MRSA and MSSA groups. Moreover, the results of this study suggest that S. aureus isolates change their common pathway for biofilm formation by acquiring methicillin resistance and the use of PIA-dependent biofilm formation pathways. This also requires further investigation.

Acknowledgment

The results described in this paper were part of student thesis and this research was supported by Grant No: 30-01-96-30525 from Iran University of Medical Sciences.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

References

  • 1.Lowy FD. Staphylococcus aureus infections. New England J Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806. [DOI] [PubMed] [Google Scholar]
  • 2.Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629. doi: 10.1038/nrmicro2200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Agarwal A, Singh KP, Jain A. Medical significance and management of Staphylococcal biofilm. FEMS Immunol Med Microbiol. 2010;58:147–160. doi: 10.1111/j.1574-695X.2009.00601.x. [DOI] [PubMed] [Google Scholar]
  • 4.Maki DG, Kluger DM, Crnich CJ, editors The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc Innov. 2006 doi: 10.4065/81.9.1159. Elsevier. [DOI] [PubMed] [Google Scholar]
  • 5.Periasamy S, Joo HS, Duong AC, Bach T-HL, Tan VY, Chatterjee SS, et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci. 2012;109:1281–1286. doi: 10.1073/pnas.1115006109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Otto M. Looking toward basic science for potential drug discovery targets against community-associated MRSA. Med Res Rev. 2010;30:1–22. doi: 10.1002/med.20160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alp E, Klaassen CH, Doganay M, Altoparlak U, Aydin K, Engin A, et al. MRSA genotypes in Turkey: persistence over 10 years of a single clone of ST239. J Infect. 2009;58:433–438. doi: 10.1016/j.jinf.2009.04.006. [DOI] [PubMed] [Google Scholar]
  • 8.Evans ME, Kralovic SM, Simbartl LA, Freyberg RW, Obrosky DS, Roselle GA, et al. Nationwide reduction of health care–associated methicillin-resistant Staphylococcus aureus infections in Veterans Affairs long-term care facilities. Am J Infect Control. 2014;42:60–62. doi: 10.1016/j.ajic.2013.06.004. [DOI] [PubMed] [Google Scholar]
  • 9.Kardaś-Słoma L, Boëlle P, Opatowski L, Brun-Buisson C, Guillemot D, Temime L. Impact of antibiotic exposure patterns on the selection of community-associated MRSA in hospital settings. Antimicrob Agents Chemother . 2011: 01626–01610. doi: 10.1128/AAC.01626-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, et al. Characterization of a isolate of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44:108–118. doi: 10.1128/JCM.44.1.108-118.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277. doi: 10.3201/eid0702.010226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ghaznavi-Rad E, Shamsudin MN, Sekawi Z, Khoon LY, Aziz MN, Hamat RA, et al. Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J Clin Microbiol. 2010;48:867–872. doi: 10.1128/JCM.01112-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. [Staphylococcus aureus biofilms: Properties, regulation and roles in human disease]; Virulence. 2011 2:445–459. doi: 10.4161/viru.2.5.17724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tormo MA, Knecht E, Götz F, Lasa I, Penades JR. Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology. 2005;151:2465–2475. doi: 10.1099/mic.0.27865-0. [DOI] [PubMed] [Google Scholar]
  • 15.Liberto MC, Matera G, Quirino A, Lamberti AG, Capicotto R, Puccio R, et al. Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques. Microbiol Res. 2009;164:522–528. doi: 10.1016/j.micres.2007.04.004. [DOI] [PubMed] [Google Scholar]
  • 16.Rohde H, Knobloch JK, Horstkotte MA, Mack D. Correlation of Staphylococcus aureus icaADBCgenotype and biofilm expression phenotype. J Clin Microbiol. 2001;39:4595–4596. doi: 10.1128/JCM.39.12.4595-4596.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rohde H, Frankenberger S, Zähringer U, Mack D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol. 2010;89:103–111. doi: 10.1016/j.ejcb.2009.10.005. [DOI] [PubMed] [Google Scholar]
  • 18.Cucarella C, Solano C, Valle J, Amorena B, Lasa Í, Penadés JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol. 2001;183:2888–2896. doi: 10.1128/JB.183.9.2888-2896.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, et al. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol. 2004;186:4665–4684. doi: 10.1128/JB.186.14.4665-4684.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Houston P, Rowe SE, Pozzi C, Waters EM, O’Gara JP. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun. 2011;79:1153–1165. doi: 10.1128/IAI.00364-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Seno Y, Kariyama R, Mitsuhata R, Monden K, Kumon H. Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama. 2005;59:79–87. doi: 10.18926/AMO/31979. [DOI] [PubMed] [Google Scholar]
  • 22.Ando E, Monden K, Mitsuhata R, Kariyama R, Kumon H. Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama. 2004;58:207–214. doi: 10.18926/AMO/32090. [DOI] [PubMed] [Google Scholar]
  • 23.Atshan SS, Shamsudin MN, Karunanidhi A, van Belkum A, Lung LTT, Sekawi Z, et al. Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA) Infection, Genetics and Evolution. 2013;18:106–112. doi: 10.1016/j.meegid.2013.05.002. [DOI] [PubMed] [Google Scholar]
  • 24.Shrestha L, Kayama S, Sasaki M, Kato F, Hisatsune J, Tsuruda K, et al. Inhibitory effects of antibiofilm compound 1 against Staphylococcus aureus biofilms. Microbiology and immunology. 2016;60:148–159. doi: 10.1111/1348-0421.12359. [DOI] [PubMed] [Google Scholar]
  • 25.Moghadam SO, Pourmand MR, Aminharati F. Biofilm formation and antimicrobial resistance in methicillin-resistant Staphylococcus aureus isolated from burn patients, Iran. J Infect Dev Ctries. 2014;8:1511–1517. doi: 10.3855/jidc.5514. [DOI] [PubMed] [Google Scholar]
  • 26.Vasudevan P, Nair MKM, Annamalai T, Venkitanarayanan KS. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Veterinary microbiology. 2003;92:179–185. doi: 10.1016/s0378-1135(02)00360-7. [DOI] [PubMed] [Google Scholar]
  • 27.Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28:1711–1720. doi: 10.1016/j.biomaterials.2006.11.046. [DOI] [PubMed] [Google Scholar]
  • 28.Oliveira A, Maria de Lourdes R. Comparison of methods for the detection of biofilm production in coagulase-negative staphylococci. BMC research notes. 2010;3:260. doi: 10.1186/1756-0500-3-260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fowler Jr VG, Fey PD, Reller LB, Chamis AL, Corey GR, Rupp ME. The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. Medical microbiology and immunology. 2001;189:127–131. doi: 10.1007/s430-001-8018-5. [DOI] [PubMed] [Google Scholar]
  • 30.Knobloch JK-M, Horstkotte MA, Rohde H, Mack D. Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Medical microbiology and immunology. 2002;191:101–106. doi: 10.1007/s00430-002-0124-3. [DOI] [PubMed] [Google Scholar]
  • 31.Kwon AS, Park GC, Ryu SY, Lim DH, Lim DY, Choi CH, et al. Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Int J Antimicrob Agents. 2008;32:68–72. doi: 10.1016/j.ijantimicag.2008.02.009. [DOI] [PubMed] [Google Scholar]
  • 32.Boles BR, Thoendel M, Roth AJ, Horswill AR. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PloS one. 2010;5:e10146. doi: 10.1371/journal.pone.0010146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.O’Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol. 2007;45:1379–1388. doi: 10.1128/JCM.02280-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.O’Neill E, Pozzi C, Houston P, Humphreys H, Robinson DA, Loughman A, et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. Journal of bacteriology. 2008;190:3835–3850. doi: 10.1128/JB.00167-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Shanks RM, Meehl MA, Brothers KM, Martinez RM, Donegan NP, Graber ML, et al. Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system. Infection and immunity. 2008;76:2469–2477. doi: 10.1128/IAI.01370-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dastgheyb S, Parvizi J, Shapiro IM, Hickok NJ, Otto M. Effect of biofilms on recalcitrance of Staphylococcal joint infection to antibiotic treatment. J Infec Dis. 2014;211:641–650. doi: 10.1093/infdis/jiu514. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Iranian Journal of Basic Medical Sciences are provided here courtesy of Mashhad University of Medical Sciences

RESOURCES